
    
      Phase III Clinical trial, to identify the most effective dose of valproic acid (20mg/kg
      bolus, 1mg/kg/h maintenance vs 40mg/kg bolus, 2mg/kg/h maintenance) in combination with
      phenytoin, in patients with refractory status epilepticus.

      Multicenter clinical trial, single-blind, prospective, randomized 1:1 assignment.
    
  